中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2010年
6期
301-304
,共4页
杨蕾%白辰光%侯晓炜%马大烈%刘晓红
楊蕾%白辰光%侯曉煒%馬大烈%劉曉紅
양뢰%백신광%후효위%마대렬%류효홍
胃肠道间质瘤%基因突变%格列卫%药物敏感性
胃腸道間質瘤%基因突變%格列衛%藥物敏感性
위장도간질류%기인돌변%격렬위%약물민감성
Gastrointestinal stromal tumor%Gene mutation%Gleevec%Drug sensitivity
目的:探讨胃肠道间质瘤相关基因突变体KIT Ins IPYD579和PDGFRA L839P对格列卫治疗的药物敏感性.方法:采用脂质体法将胃肠道间质瘤相关基因突变体KIT De1559-560、KIT Ins IPYD579、PDGFRA D842V及PDGFRA L839P重组质粒分别瞬时转染中国仓鼠卵巢上皮细胞系(CHO),表达24h后与格列卫共孵育90min,用Western-blot法检测的相关蛋白表达及其磷酸化状态.另外,用MTT法检测各组稳转PDGFRA基因突变体的CHO细胞与不同浓度格列卫共孵育72h后的增殖变化.结果:当格列卫浓度为0.1μM时,转染KIT De1559-560重组质粒的CHO细胞磷酸化KIT蛋白表达量明显降低.当格列卫浓度为1μM时,转染KIT Ins IPYD579和PDGFRA L839P重组质粒的CHO细胞的相应蛋白磷酸化形式不能检出.而转染PDGFRA D842V重组质粒的CHO细胞直至格列卫浓度提高至5μM时,其磷酸化PDGFRA蛋白表达水平仍无明显降低.MTT法显示:当格列卫浓度提高至1μM时,转染PDGFRA L839P重组质粒的CHO细胞增殖百分比明显降低,而转染PDGFRA D842V重组质粒的CHO细胞增殖百分比直至格列卫浓度为5μM时仍无明显变化.结论:格列卫在短时间内可使PDGFRA L839P或KIT Ins IPYD579突变体磷酸化蛋白表达减少,长期作用时对表达PDGFRA L839P突变体的细胞增殖具有明显的抑制作用.
目的:探討胃腸道間質瘤相關基因突變體KIT Ins IPYD579和PDGFRA L839P對格列衛治療的藥物敏感性.方法:採用脂質體法將胃腸道間質瘤相關基因突變體KIT De1559-560、KIT Ins IPYD579、PDGFRA D842V及PDGFRA L839P重組質粒分彆瞬時轉染中國倉鼠卵巢上皮細胞繫(CHO),錶達24h後與格列衛共孵育90min,用Western-blot法檢測的相關蛋白錶達及其燐痠化狀態.另外,用MTT法檢測各組穩轉PDGFRA基因突變體的CHO細胞與不同濃度格列衛共孵育72h後的增殖變化.結果:噹格列衛濃度為0.1μM時,轉染KIT De1559-560重組質粒的CHO細胞燐痠化KIT蛋白錶達量明顯降低.噹格列衛濃度為1μM時,轉染KIT Ins IPYD579和PDGFRA L839P重組質粒的CHO細胞的相應蛋白燐痠化形式不能檢齣.而轉染PDGFRA D842V重組質粒的CHO細胞直至格列衛濃度提高至5μM時,其燐痠化PDGFRA蛋白錶達水平仍無明顯降低.MTT法顯示:噹格列衛濃度提高至1μM時,轉染PDGFRA L839P重組質粒的CHO細胞增殖百分比明顯降低,而轉染PDGFRA D842V重組質粒的CHO細胞增殖百分比直至格列衛濃度為5μM時仍無明顯變化.結論:格列衛在短時間內可使PDGFRA L839P或KIT Ins IPYD579突變體燐痠化蛋白錶達減少,長期作用時對錶達PDGFRA L839P突變體的細胞增殖具有明顯的抑製作用.
목적:탐토위장도간질류상관기인돌변체KIT Ins IPYD579화PDGFRA L839P대격렬위치료적약물민감성.방법:채용지질체법장위장도간질류상관기인돌변체KIT De1559-560、KIT Ins IPYD579、PDGFRA D842V급PDGFRA L839P중조질립분별순시전염중국창서란소상피세포계(CHO),표체24h후여격렬위공부육90min,용Western-blot법검측적상관단백표체급기린산화상태.령외,용MTT법검측각조은전PDGFRA기인돌변체적CHO세포여불동농도격렬위공부육72h후적증식변화.결과:당격렬위농도위0.1μM시,전염KIT De1559-560중조질립적CHO세포린산화KIT단백표체량명현강저.당격렬위농도위1μM시,전염KIT Ins IPYD579화PDGFRA L839P중조질립적CHO세포적상응단백린산화형식불능검출.이전염PDGFRA D842V중조질립적CHO세포직지격렬위농도제고지5μM시,기린산화PDGFRA단백표체수평잉무명현강저.MTT법현시:당격렬위농도제고지1μM시,전염PDGFRA L839P중조질립적CHO세포증식백분비명현강저,이전염PDGFRA D842V중조질립적CHO세포증식백분비직지격렬위농도위5μM시잉무명현변화.결론:격렬위재단시간내가사PDGFRA L839P혹KIT Ins IPYD579돌변체린산화단백표체감소,장기작용시대표체PDGFRA L839P돌변체적세포증식구유명현적억제작용.
Objective: To explore the sensitivity of Kit or PDGFRA mutants related to gastrointestinal stromal tumor (GIST) to Gleevec.Methods: The recombinant plasmids of KIT Del559-560, KIT Ins IPYD579, PDGFRA D842V and PDG-FRA L839P gene mutants were transiently transformed into the CHO cells by liposome methods.Western blot was used to detect the expression of the related protein and their phosphorylated forms after the cells were incubated with Gleevec for 90 min.At 72 hours after incubation with Gleevec, MTT was used to detect cell proliferation.Results: Western blot results showed that Gleevec at 0.1 μM can notably reduce phosphorylation of KIT Del559-560.Gleevec at 1μM completely blocked phosphorylation of KIT Ins IPYD579 and PDGFRA L839P, but did not affect PDGFRA D842V phosphorylation.MTT analy-sis indicated that growth of CHOPDGFRA L839P was inhibited by Gleevec at 1μM, however, CHOPDGFRA D842V was re-sistant to Gleevec at 5 μM.Conclusion: Gleevec can decrease the expression of phosphorylated protein CHOPDGFRA L839P and CHOKIT Ins IPYD579, and can remarkably inhibit the proliferation of cells containing PDGFRA L839P mutant.